y Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study

Zamarin, D; Hamid, O; Nayak-Kapoor, A; Sahebjam, S; Sznol, M; Collaku, A; Fox, FE; Marshall, MA; Hong, DS

Zamarin, D (corresponding author), Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1313, New York, NY 10065 USA.; Hong, DS (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 455, Houston, TX 77030 USA.

CLINICAL CANCER RESEARCH, 2020; 26 (17): 4531

Abstract

Purpose: The study goal was to determine safety, antitumor activity, and pharmacodynamic profile of mogamulizumab, an anti-C-C chemokine receptor 4 (a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索